Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-04 02:37:21 - browse：5

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： ASCO: Palliative care found as helpful given virtually as in person

explore

WSS

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Microbiome research is starting to find links to chronic diseases

Shifting the focus from loneliness to social health

Cord blood banking comes at a high cost to babies

Ultragenyx gene therapy for rare liver ailment succeeds in late

With trial win, GSK could get blood cancer drug back on market

Wikipedia

Wikipedia

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA's Pazdur wants cancer trials to range beyond China alone

Cancer drug shortages should be causing more outrage

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Affirmative action in medical school literally saved lives

Lasker Awards 2023: Winners in biomedical research

Virginia high school admissions case could be legal follow

Second xenotransplant done with gene

Cancer drug shortages should be causing more outrage

At ASCO, AstraZeneca reports strong data for breast cancer drug

leisure time

Biotech stock slump in 2023: awaiting the turnaround

Innovation in antibiotics is ailing. 'Brain drain' may kill it

STAT Virtual Event: Putting AI to the Test

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Readout LOUD podcast: possible new ALS drug, artificial wombs

Letters to First Opinion on caregivers, digital health, and more

hotspot

focus

explore

entertainment